Search

everythinglearnresearchcommunity

for

Search:↓

Pattern hair loss is mainly caused by genetics and hormones, with limited effective treatments available.

The document concludes that understanding sulfation biology is crucial for creating treatments due to its importance in biological functions and disease.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

A mix of Polygonatum sibiricum and Nelumbinis semen may ease menopause symptoms with fewer side effects.

Trichotillomania is a chronic hair-pulling disorder, more common in females, treated with therapy and sometimes medication.

Combined finasteride and anastrozole therapy effectively treats BPH, influenced by hormone imbalances and genetics.

Combining medication for dyslipidemia and insulin resistance with basic therapy improves outcomes for alopecia areata with metabolic syndrome.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Biotin mega-dose therapy led to dramatic improvement in a newborn with a rare metabolic disorder.

Enhancing glycolysis in mesenchymal stromal/stem cells boosts their immune functions and therapy potential.

Angelica gigas Nakai root extracts may help with cancer, pain, memory loss, and metabolic issues.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Lactate is vital for skin health, influencing metabolism, the skin barrier, immune responses, and has therapeutic potential for skin disorders.

Combination therapy helped patient with advanced Hidradenitis Suppurativa achieve remission.

Two rare genetic diseases cause severe rickets in children due to defects in vitamin D metabolism.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Hair loss is linked to heart disease and metabolic syndrome, and while current treatments vary in effectiveness, more research is needed for better solutions.

Scalp cooling and low-power light therapy show promise in reducing chemotherapy-induced hair loss but need more research.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.

Targeting glycolysis may help treat PCOS by improving insulin sensitivity and ovarian function.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

Biotin supplements are not proven to improve hair or nails and may interfere with medical tests.

Melatonin may help treat PCOS symptoms in rats.

In teens with Polycystic Ovary Syndrome and obesity, issues related to metabolism, skin, and mental health are common, and a clinic with various specialists can provide care for most of these problems.

Disruptions in sleep-wake cycles can cause health problems like mental, metabolic, and heart diseases, and cancer.

Albendazole treatment for echinococcosis can cause serious side effects and requires close monitoring.

Enzyme replacement therapy improved multiple symptoms of homocystinuria in mice.

Antiandrogen therapy is effective and well tolerated for treating women's androgenic disorders like hirsutism, acne, and hair loss.

20% of patients with androgenic alopecia also had metabolic syndrome.

5-aminolevulinic acid therapy reduces acne by decreasing fat production in skin cells.